# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Ekaterina Knyazkova initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and ann...
B of A Securities analyst Derik De Bruin maintains Phibro Animal Health (NASDAQ:PAHC) with a Underperform and raises the pri...
Adjusted EBITDA of $118 million to $126 million
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of ...
Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and raises the price target f...
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of ...